Methimazole as an antioxidant and immunomodulator in thyroid cells : mechanisms involving interferon-γ signaling and H2O2 scavenging

Cited 49 time in scopus
Metadata Downloads

Full metadata record

DC FieldValueLanguage
dc.contributor.authorHo Kim-
dc.contributor.authorTae Hoon Lee-
dc.contributor.authorYoung Sun Hwang-
dc.contributor.authorMi Ae Bang-
dc.contributor.authorKang Hwa Kim-
dc.contributor.authorJae Mi Suh-
dc.contributor.authorHyo Kyun Chung-
dc.contributor.authorDae Yeul Yu-
dc.contributor.authorKyung Kwang Lee-
dc.contributor.authorO Yu Kwon-
dc.contributor.authorHong Kyu Ro-
dc.contributor.authorMin Ho Shong-
dc.date.accessioned2017-04-19T08:58:29Z-
dc.date.available2017-04-19T08:58:29Z-
dc.date.issued2001-
dc.identifier.issn0026-895X-
dc.identifier.urihttps://oak.kribb.re.kr/handle/201005/5618-
dc.description.abstractThe antithyroid drug, methimazole (MMI) is used to treat patients with Graves' hyperthyroidism. The major action of MMI is to inhibit synthesis of thyroid hormone in the thyroid gland. However, MMI also has antioxidant and immunomodulatory effects on thyrocytes and/or immune cells. This study identifies novel antioxidant and immunomodulatory effects of MMI involving the interferon-γ (IFN-γ) signaling pathway in thyroid cells. MMI inhibits transcription of the intercellular adhesion molecule-1 (ICAM-1) gene by modulating the function of transcription factor STAT1 (signal transducer and activator of transcription 1), which binds to the IFN-γ activated site of the ICAM-1 promoter. Furthermore, MMI rapidly eliminates H2O2 produced by IFN-γ treatment in thyroid cells and thus inhibits the H2O2-mediated phosphorylation of tyrosine 701 in STAT1. MMI also eliminates H2O2 in vitro. MMI facilitates electron transfer from NADPH to H2O2 using thioredoxin or glutathione, fulfilling a role similar to peroxiredoxin or glutathione peroxidase, respectively. MMI prevents the IFN-γ and H2O2-mediated reversible inactivation of phosphatases. These effects inhibit full activation of the IFN-γ-induced Janus kinase(JAK)/STAT signaling pathway in FRTL-5 thyroid cells. These results may in part explain the antioxidant and immunomodulatory effects of MMI in thyroid cells of Graves' disease patients.-
dc.publisherAmer Soc Pharmacology Experimental Therapeutics-
dc.titleMethimazole as an antioxidant and immunomodulator in thyroid cells : mechanisms involving interferon-γ signaling and H2O2 scavenging-
dc.title.alternativeMethimazole as an antioxidant and immunomodulator in thyroid cells : mechanisms involving interferon-γ signaling and H2O2 scavenging-
dc.typeArticle-
dc.citation.titleMolecular Pharmacology-
dc.citation.number5-
dc.citation.endPage980-
dc.citation.startPage972-
dc.citation.volume60-
dc.contributor.affiliatedAuthorTae Hoon Lee-
dc.contributor.affiliatedAuthorDae Yeul Yu-
dc.contributor.affiliatedAuthorKyung Kwang Lee-
dc.contributor.alternativeName김호-
dc.contributor.alternativeName이태훈-
dc.contributor.alternativeName황영선-
dc.contributor.alternativeName방미애-
dc.contributor.alternativeName김광화-
dc.contributor.alternativeName서재미-
dc.contributor.alternativeName정효균-
dc.contributor.alternativeName유대열-
dc.contributor.alternativeName이경광-
dc.contributor.alternativeName권오유-
dc.contributor.alternativeName노홍규-
dc.contributor.alternativeName송민호-
dc.identifier.bibliographicCitationMolecular Pharmacology, vol. 60, no. 5, pp. 972-980-
dc.identifier.doi10.1124/mol.60.5.972-
dc.description.journalClassY-
Appears in Collections:
1. Journal Articles > Journal Articles
Files in This Item:
  • There are no files associated with this item.


Items in OpenAccess@KRIBB are protected by copyright, with all rights reserved, unless otherwise indicated.